TWO Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity At-the-Market Offering (Details)

Stockholders' Equity At-the-Market Offering (Details) - USD ($) $ in Thousands	3 Months Ended						9 Months Ended
	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Sep. 30, 2023	Sep. 30, 2022
Subsidiary, Sale of Stock [Line Items]
Number of shares authorized to be sold under equity distribution agreement (in shares)	11,000,000						11,000,000
Number of common shares issued under equity distribution agreement and outstanding as of period-end (in shares)	2,300,605						2,300,605
Accumulated proceeds from issuance of common shares under equity distribution agreement	$ 136,900						$ 136,900
Issuance of stock, net of offering costs	$ 48	$ 149	$ 177,729	$ 5,357	$ 82	$ 323
At the Market Offering [Member]
Subsidiary, Sale of Stock [Line Items]
Number of shares of stock issued during period (in shares)	0			259,500			117,427	259,500
Issuance of stock, net of offering costs	$ 0			$ 5,300			$ 2,100	$ 5,300

Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.

+ References + Details